RadNet (NASDAQ: RDNT) reported Q1 EPS of ($0.03), $0.04 worse than the analyst estimate of $0.01. Revenue for the quarter came in at $229 million versus the consensus estimate of $222.88 million.

• Total Net Revenue (“Revenue”) increased 5.8% to $229.0 million in the first quarter of 2017 from $216.4 million in the first quarter of 2016
• Adjusted EBITDA(1) increased 5.8% to $28.7 in the first quarter of 2017 from $27.1 million in the first quarter of 2016
• Diluted loss per share was $(0.03) per share in the first quarter of 2017, flat from the prior year’s first quarter
• Aggregate procedural volumes increased 2.5% and same center volumes increased 2.1% as compared with the first quarter of 2016
• Established two joint ventures with Cedars-Sinai in the greater Los Angeles area
• Exited the Rhode Island marketplace through the sale of its five imaging centers

RadNet reaffirms its previously announced 2017 guidance ranges.

For earnings history and earnings-related data on RadNet (RDNT) click here
.